Form 4 for ADPT Adaptive Biotechnologies Corp
Accepted 2026-06-15 19:13:00 ET · period of report 2026-06-11 · accession 0001820885-26-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-15 19:13 | 2026-06-11 | ADPT | BOBULSKY SUSAN | Chief Commercial Off, MRD | S - Sale | $19.00 | -5,000 | 411.8K | -1% | -$95.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-11 | S | D | 5,000 | $19.00 | 411,775 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025. |